ONCOCROSS CO.,LTD.ONCOCROSS CO.,LTD.ONCOCROSS CO.,LTD.

ONCOCROSS CO.,LTD.

No trades
See on Supercharts

382150 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Oncocross Co., Ltd. engages in conducting joint research on new drugs with several domestic and foreign pharmaceutical companies. It provides a new approach to new drug development by sharing the analysis results using AI new drug development platform. The company was founded by Yi-Rang Kim on June 22, 2015 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
382150 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company